GSK Investigational Site

Belo Horizonte, Minas Gerais 30150-221

0 studies enrolling now · 6 studies all time

What they study most

Anaemia, Aspergillosis, Allergic Bronchopulmonary, Lupus Nephritis, Neoplasms, Head and Neck, Systemic Lupus Erythematosus

Studies at this site

• Belimumab Assessment of Safety in SLE — Completed
• Study of GSK3359609 and Pembrolizumab in Programmed Death Receptor 1-ligand 1 (PD-L1) Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma — Stopped early
• Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Dialysis (ASCEND-D) — Completed
• Efficacy and Safety of Belimumab in Black Race Patients With Systemic Lupus Erythematosus (SLE) — Completed
• Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-Three-times Weekly Dosing in Dialysis (ASCEND-TD) — Completed
• Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis — Completed